NEW DELHI: India’s drug regulatory body Drug Controller General of India has approved a new treatment designed to eliminate the need for reading glasses for millions of people suffering from presbyopia, a common age-related vision ailment that impacts those aged above 40.
The Mumbai-based Entod Pharmaceuticals has developed PresVu Eye Drops, aimed at treating this age-related vision condition, which affects between 1.09 billion and 1.80 billion people worldwide.
Presbyopia has long been managed with reading glasses, contact lenses and surgical interventions, but now the eye drop offers an advanced alternative that augments near vision within 15 minutes.
Presvu has also applied for a patent for this invention in terms of its formulation and the process. The proprietary formula not only gets rid of reading glasses but also helps lubricate the eyes as a side benefit.
These eye drops utilise advanced dynamic buffer technology to swiftly adapt to tear pH, ensuring consistent efficacy and safety for extended use, keeping in mind that such drops will be used for years at a stretch, the pharma firm said.
Presbyopia occurs as a natural consequence of aging when the eye’s ability to focus diminishes, leading to difficulty in focusing on close objects. This can significantly impact a person’s quality of life.
For patients with presbyopia, the eye drop offers a non-invasive option that can enhance near vision without the need for reading glasses.
“PresVu is the result of years of dedicated research and development. This DCGI approval is a major step forward in our mission to transform eye care in India,” said Nikkhil K Masurkar, CEO, Entod Pharmaceuticals.
“This new option is set to greatly improve the quality of life for many. It’s important to monitor symptoms and seek medical advice if blurry close-up vision interferes with reading,” the statement said.
Ailment
Presbyopia occurs as a natural consequence of aging, when the eye’s ability to focus diminishes, leading to difficulty in focusing on close objects
The ailment has long been managed with reading glasses, contact lenses and surgical interventions
Treatment
PresVu Eye Drops developed by Mumbai-based Entod Pharmaceuticals augments near vision within 15 minutes, eliminating the need for reading glasses
These eye drops utilise advanced dynamic buffer technology to swiftly adapt to tear pH, ensuring consistent efficacy and safety for extended use